Keith Regnante, CFO: Keros Therapeutics KROS Sell · Filed 02/20

Trade details

Type: Insider sale
Amount: $77,482.65
Shares · price: 4,739 sh · $16.35 a share
Held after: 39,261 sh
Stock: Keros Therapeutics KROS
Person: Keith RegnanteCFO
Trade date: 26/02/18
Filed: 26/02/20
Days to filing: 2 days

Sold 10.8% of holdings

Share of holding sold: 10.8%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Keith Regnante's recent trades

Keith RegnanteCFO
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$1.8M
40,000 sh
$1.8M
Filed 25/01/24
Traded 24/01/04
Keith RegnanteCFO
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$1.8M
40,000 sh
$1.8M
Filed 24/01/08
Traded 23/11/04
Keith RegnanteCFO
Sell10b5-1 planKeros Therapeutics
Sell10b5-1 plan
Keros Therapeutics
KROS
$824.6K
17,301 sh
$824.6K
Filed 23/06/12
Traded 23/06/08
Keith RegnanteCFO
Sell10b5-1 planKeros Therapeutics
Sell10b5-1 plan
Keros Therapeutics
KROS
$720.2K
15,993 sh
$720.2K
Filed 23/06/12
Traded 23/06/09
Keith RegnanteCFO
Sell10b5-1 planKeros Therapeutics
Sell10b5-1 plan
Keros Therapeutics
KROS
$131.3K
2,699 sh
$131.3K
Filed 23/06/12
Traded 23/06/08